These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 19327613

  • 1. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E, Harper P, Andersson DE, Floderus Y.
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [Abstract] [Full Text] [Related]

  • 2. Acute intermittent porphyria in childhood: a population-based study.
    Hultdin J, Schmauch A, Wikberg A, Dahlquist G, Andersson C.
    Acta Paediatr; 2003 May; 92(5):562-8. PubMed ID: 12839285
    [Abstract] [Full Text] [Related]

  • 3. Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes.
    Sardh E, Andersson DE, Henrichson A, Harper P.
    Cell Mol Biol (Noisy-le-grand); 2009 Feb 16; 55(1):66-71. PubMed ID: 19268004
    [Abstract] [Full Text] [Related]

  • 4. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
    Floderus Y, Sardh E, Möller C, Andersson C, Rejkjaer L, Andersson DE, Harper P.
    Clin Chem; 2006 Apr 16; 52(4):701-7. PubMed ID: 16497943
    [Abstract] [Full Text] [Related]

  • 5. A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen.
    Zhang J, Yasuda M, Desnick RJ, Balwani M, Bishop D, Yu C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug 15; 879(24):2389-96. PubMed ID: 21783436
    [Abstract] [Full Text] [Related]

  • 6. Early administration of heme arginate for acute porphyric attacks.
    Mustajoki P, Nordmann Y.
    Arch Intern Med; 1993 Sep 13; 153(17):2004-8. PubMed ID: 8357285
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT, Rees DC.
    J Clin Pathol; 2014 Jan 13; 67(1):60-5. PubMed ID: 23908454
    [Abstract] [Full Text] [Related]

  • 8. Molecular diagnostics of acute intermittent porphyria.
    Kauppinen R.
    Expert Rev Mol Diagn; 2004 Mar 13; 4(2):243-9. PubMed ID: 14995910
    [Abstract] [Full Text] [Related]

  • 9. Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver.
    Yasuda M, Erwin AL, Liu LU, Balwani M, Chen B, Kadirvel S, Gan L, Fiel MI, Gordon RE, Yu C, Clavero S, Arvelakis A, Naik H, Martin LD, Phillips JD, Anderson KE, Sadagoparamanujam VM, Florman SS, Desnick RJ.
    Mol Med; 2015 Jun 05; 21(1):487-95. PubMed ID: 26062020
    [Abstract] [Full Text] [Related]

  • 10. Direct and simultaneous determination of 5-aminolaevulinic acid and porphobilinogen in urine by hydrophilic interaction liquid chromatography-electrospray ionisation/tandem mass spectrometry.
    Benton CM, Couchman L, Marsden JT, Rees DC, Moniz C, Lim CK.
    Biomed Chromatogr; 2012 Aug 05; 26(8):1033-40. PubMed ID: 22740490
    [Abstract] [Full Text] [Related]

  • 11. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
    Sardh E, Rejkjaer L, Andersson DE, Harper P.
    Clin Pharmacokinet; 2007 Aug 05; 46(4):335-49. PubMed ID: 17375984
    [Abstract] [Full Text] [Related]

  • 12.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Sardh E, Barbaro M.
    ; 1993 Aug 05. PubMed ID: 20301372
    [Abstract] [Full Text] [Related]

  • 13. Direct and simultaneous quantitation of 5-aminolaevulinic acid and porphobilinogen in human serum or plasma by hydrophilic interaction liquid chromatography-atmospheric pressure chemical ionization/tandem mass spectrometry.
    Benton CM, Couchman L, Marsden JT, Rees DC, Moniz C, Lim CK.
    Biomed Chromatogr; 2013 Feb 05; 27(2):267-72. PubMed ID: 23180457
    [Abstract] [Full Text] [Related]

  • 14. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL, Healey JF, Lourie AN, Gerron GG.
    Am J Gastroenterol; 1991 Aug 05; 86(8):1050-6. PubMed ID: 1713408
    [Abstract] [Full Text] [Related]

  • 15. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR, Manorajan R, Sathiyakumar D, Soundararajan P, Jayakumar M.
    Hemodial Int; 2008 Jan 05; 12(1):34-8. PubMed ID: 18271838
    [Abstract] [Full Text] [Related]

  • 16. Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.
    Yasuda M, Gan L, Chen B, Yu C, Zhang J, Gama-Sosa MA, Pollak DD, Berger S, Phillips JD, Edelmann W, Desnick RJ.
    Hum Mol Genet; 2019 Jun 01; 28(11):1755-1767. PubMed ID: 30615115
    [Abstract] [Full Text] [Related]

  • 17. Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.
    Johansson A, Möller C, Fogh J, Harper P.
    Mol Med; 2003 Jun 01; 9(9-12):193-9. PubMed ID: 15208740
    [Abstract] [Full Text] [Related]

  • 18. Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model.
    Vera-Yunca D, Serrano-Mendioroz I, Sampedro A, Jericó D, Trocóniz IF, Fontanellas A, Parra-Guillén ZP.
    Mol Genet Metab; 2019 Nov 01; 128(3):367-375. PubMed ID: 30639045
    [Abstract] [Full Text] [Related]

  • 19. Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species.
    Lelli SM, San Martín de Viale LC, Mazzetti MB.
    Toxicology; 2005 Dec 01; 216(1):49-58. PubMed ID: 16125296
    [Abstract] [Full Text] [Related]

  • 20. [Nephrologists and porphyrias].
    Canavese C, Gabrielli D, Guida C, Cappellini MD.
    G Ital Nefrol; 2002 Dec 01; 19(4):393-412. PubMed ID: 12369042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.